Patents by Inventor Noel Vera-Gonzalez

Noel Vera-Gonzalez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240374792
    Abstract: The present disclosure describes improved polymer compositions, such as GelMA polymer compositions. In certain embodiments, the improved polymer compositions can be used as a soft-tissue adhesive for use in sealing, repairing and/or treating injuries, defects, or diseases in the soft tissue of a subject. In certain embodiments, the improved polymer compositions are hydrogels which can comprise gelatin methacryloyl (i.e., GelMA) or polymerically crosslinked derivatives thereof.
    Type: Application
    Filed: September 15, 2022
    Publication date: November 14, 2024
    Inventors: Max COTLER, Noel VERA-GONZALEZ, Arthur DRISCOLL, Eric HUANG
  • Publication number: 20220265833
    Abstract: The present invention relates generally to antifungal hydrogels to locally deliver antifungal drugs. Specifically, the present invention provides aspartic protease-triggered antifungal hydrogels to locally deliver antifungal drugs that specifically respond to aspartic proteases secreted by virulent, pathogenic Candida.
    Type: Application
    Filed: February 28, 2022
    Publication date: August 25, 2022
    Inventors: Anita SHUKLA, Noel VERA-GONZALEZ
  • Publication number: 20220160631
    Abstract: The invention provides functionalized antifungal-loaded liposomal formulations targeting Candida, which minimize damage to healthy human cells, limit antimicrobial exposure, and reduce the development of antifungal resistance.
    Type: Application
    Filed: January 31, 2022
    Publication date: May 26, 2022
    Inventors: Anita Shukla, Sarah Cowles, Noel Vera-Gonzalez, Christina Bailey-Hytholt, Eli Silvert
  • Patent number: 11273124
    Abstract: The invention provides functionalized antifungal-loaded liposomal formulations targeting Candida, which minimize damage to healthy human cells, limit antimicrobial exposure, and reduce the development of antifungal resistance.
    Type: Grant
    Filed: March 24, 2020
    Date of Patent: March 15, 2022
    Assignee: Brown University
    Inventors: Anita Shukla, Sarah Cowles, Noel Vera-Gonzalez, Christina Bailey-Hytholt, Eli Silvert
  • Publication number: 20200368160
    Abstract: The invention provides functionalized antifungal-loaded liposomal formulations targeting Candida, which minimize damage to healthy human cells, limit antimicrobial exposure, and reduce the development of antifungal resistance.
    Type: Application
    Filed: March 24, 2020
    Publication date: November 26, 2020
    Inventors: Anita Shukla, Sarah Cowles, Noel Vera-Gonzalez, Christina Bailey-Hytholt, Eli Silvert
  • Publication number: 20190151455
    Abstract: The present invention relates generally to antifungal hydrogels to locally deliver antifungal drugs. Specifically, the present invention provides aspartic protease-triggered antifungal hydrogels to locally deliver antifungal drugs that specifically respond to aspartic proteases secreted by virulent, pathogenic Candida.
    Type: Application
    Filed: October 15, 2018
    Publication date: May 23, 2019
    Inventors: Anita Shukla, Noel Vera-Gonzalez